Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Primary Care Visits For Breast Symptoms And The Frequency Of Cancer Diagnosis
http://www.medicalnewstoday.com/articles/128925.php
A study of 84,285 women seeking care in Dutch family physician offices between 1985 and 2003 revealed that breast symptoms were reported in about 3 percent of all visits. Of the women complaining of breast symptoms, 3 percent of those women were subsequently diagnosed with breast cancer.
Karmanos Cancer Institute Seeks Breast Cancer Patients To Participate In A New Drug Trial
http://www.medicalnewstoday.com/articles/128854.php
The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an international study to further test a new drug Trastuzumab-DM1, in development by Genentech.
Karmanos Cancer Institute Seeks Breast Cancer Patients To Participate In A New Drug Trial
http://www.medicalnewstoday.com/articles/128838.php
The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an international study to further test a new drug Trastuzumab-DM1, in development by Genentech.
----------------------------------------------
** CANCER / ONCOLOGY News **
Despite Promising Laboratory Data Bone Cancer Treatment Ineffective
http://www.medicalnewstoday.com/articles/128860.php
Ewing sarcoma is the second most common type of primary bone cancer seen in children and young adults. Patients with relapsed or refractory Ewing sarcoma have a poor outcome with conventional therapies.
UK Experts Warn About Untested Remedies And Issue Guide To Consumers
http://www.medicalnewstoday.com/articles/128858.php
Medical experts from UK charities concerned about the rise in miracle cure stories, wonder drugs and so-called breakthrough therapies have teamed up to produce a guide that explains how to tell the beneficial from the bogus.
Cancer Drug Consultation Flawed, Say Campaigners, Keep Our NHS Public Says, UK
http://www.medicalnewstoday.com/articles/128727.php
There is no reason why the best drugs cannot be available to all NHS patients, the Keep Our NHS Public campaign has said, but the Government has wrongly excluded this option from the current consultation over cancer drugs.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Advanced Metastatic Colorectal Cancer - FUSILEV™ Receives Unique, Product-Specific J-Code From The CMS, USA
http://www.medicalnewstoday.com/articles/128731.php
Spectrum Pharmaceuticals, Inc., (NasdaqGM:SPPI) announced today that the Centers for Medicare and Medicaid Services (CMS), under the Medicare Part B benefit, has assigned a unique, product-specific billing code, or J-code, for FUSILEV™ (levoleucovorin).
----------------------------------------------
** LUNG CANCER News **
EntreMed's MKC-1 Meets Primary Efficacy Endpoint In Non-Small Cell Lung Cancer Clinical Trial
http://www.medicalnewstoday.com/articles/128847.php
EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced that it has met the primary endpoint for the efficacy portion of the open label Phase 1/2 study of MKC-1 in combination with pemetrexed (Alimta(R)) in non-small cell lung cancer patients.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Genmab A/S: Ofatumumab Pivotal CLL Data To Be Presented At ASH
http://www.medicalnewstoday.com/articles/128840.php
Genmab A/S (OMX: GEN) announced that three ofatumumab (HuMax-CD20(R)) abstracts have been accepted for presentation at the 50th American Society of Hematology Annual Meeting and Exposition (ASH) December 6-9, 2008.
Researchers Aim To Over-stress Already Taxed Mantle Cell Lymphoma Cells
http://www.medicalnewstoday.com/articles/128832.php
Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them. "Think about an assembly line in a factory that is working five times faster than normal," said Dr.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment